Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance

Many tumor cells express chemokines and chemokine receptors, and, for this reason, these molecules can affect the tumor progression. It is known that breast cancer is a complex and heterogeneous neoplasia comprising distinct diseases, histological characteristics, and clinical outcomes. The most stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina Okuyama Kishima, Carlos Eduardo Coral de Oliveira, Bruna Karina Banin-Hirata, Roberta Losi-Guembarovski, Karen Brajão de Oliveira, Marla Karine Amarante, Maria Angelica Ehara Watanabe
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2015/891020
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547242372759552
author Marina Okuyama Kishima
Carlos Eduardo Coral de Oliveira
Bruna Karina Banin-Hirata
Roberta Losi-Guembarovski
Karen Brajão de Oliveira
Marla Karine Amarante
Maria Angelica Ehara Watanabe
author_facet Marina Okuyama Kishima
Carlos Eduardo Coral de Oliveira
Bruna Karina Banin-Hirata
Roberta Losi-Guembarovski
Karen Brajão de Oliveira
Marla Karine Amarante
Maria Angelica Ehara Watanabe
author_sort Marina Okuyama Kishima
collection DOAJ
description Many tumor cells express chemokines and chemokine receptors, and, for this reason, these molecules can affect the tumor progression. It is known that breast cancer is a complex and heterogeneous neoplasia comprising distinct diseases, histological characteristics, and clinical outcomes. The most studied role for CXCL12 chemokine and its receptor CXCR4 in breast cancer pathogenesis is the metastasis event, although several reports have demonstrated its involvement in other processes, such as angiogenesis and tumor growth. It has been found that CXCR4 is required for breast cancer cell migration to other sites such as lung, bone, and lymph nodes, which express high levels of CXCL12 chemokine. Therefore, CXCR4 is being considered a prognostic marker in breast cancer. Within this context, this review summarizes established studies involving expression of CXCR4 on breast cancer, focusing on its clinical significance.
format Article
id doaj-art-9fa0bfe3f6604b17a19e84a059a7634f
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-9fa0bfe3f6604b17a19e84a059a7634f2025-02-03T06:45:28ZengWileyAnalytical Cellular Pathology2210-71772210-71852015-01-01201510.1155/2015/891020891020Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical SignificanceMarina Okuyama Kishima0Carlos Eduardo Coral de Oliveira1Bruna Karina Banin-Hirata2Roberta Losi-Guembarovski3Karen Brajão de Oliveira4Marla Karine Amarante5Maria Angelica Ehara Watanabe6Laboratory of Human Pathology, Department of Pathology, Clinical Analysis and Toxicology, Health Sciences Center, University Hospital of Londrina, State University of Londrina, 86038-350 Londrina, PR, BrazilLaboratory of Study and Application of DNA Polymorphisms and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, 86057-970 Londrina, PR, BrazilLaboratory of Study and Application of DNA Polymorphisms and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, 86057-970 Londrina, PR, BrazilLaboratory of Study and Application of DNA Polymorphisms and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, 86057-970 Londrina, PR, BrazilLaboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, 86057-970 Londrina, PR, BrazilLaboratory of Study and Application of DNA Polymorphisms and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, 86057-970 Londrina, PR, BrazilLaboratory of Study and Application of DNA Polymorphisms and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, 86057-970 Londrina, PR, BrazilMany tumor cells express chemokines and chemokine receptors, and, for this reason, these molecules can affect the tumor progression. It is known that breast cancer is a complex and heterogeneous neoplasia comprising distinct diseases, histological characteristics, and clinical outcomes. The most studied role for CXCL12 chemokine and its receptor CXCR4 in breast cancer pathogenesis is the metastasis event, although several reports have demonstrated its involvement in other processes, such as angiogenesis and tumor growth. It has been found that CXCR4 is required for breast cancer cell migration to other sites such as lung, bone, and lymph nodes, which express high levels of CXCL12 chemokine. Therefore, CXCR4 is being considered a prognostic marker in breast cancer. Within this context, this review summarizes established studies involving expression of CXCR4 on breast cancer, focusing on its clinical significance.http://dx.doi.org/10.1155/2015/891020
spellingShingle Marina Okuyama Kishima
Carlos Eduardo Coral de Oliveira
Bruna Karina Banin-Hirata
Roberta Losi-Guembarovski
Karen Brajão de Oliveira
Marla Karine Amarante
Maria Angelica Ehara Watanabe
Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance
Analytical Cellular Pathology
title Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance
title_full Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance
title_fullStr Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance
title_full_unstemmed Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance
title_short Immunohistochemical Expression of CXCR4 on Breast Cancer and Its Clinical Significance
title_sort immunohistochemical expression of cxcr4 on breast cancer and its clinical significance
url http://dx.doi.org/10.1155/2015/891020
work_keys_str_mv AT marinaokuyamakishima immunohistochemicalexpressionofcxcr4onbreastcanceranditsclinicalsignificance
AT carloseduardocoraldeoliveira immunohistochemicalexpressionofcxcr4onbreastcanceranditsclinicalsignificance
AT brunakarinabaninhirata immunohistochemicalexpressionofcxcr4onbreastcanceranditsclinicalsignificance
AT robertalosiguembarovski immunohistochemicalexpressionofcxcr4onbreastcanceranditsclinicalsignificance
AT karenbrajaodeoliveira immunohistochemicalexpressionofcxcr4onbreastcanceranditsclinicalsignificance
AT marlakarineamarante immunohistochemicalexpressionofcxcr4onbreastcanceranditsclinicalsignificance
AT mariaangelicaeharawatanabe immunohistochemicalexpressionofcxcr4onbreastcanceranditsclinicalsignificance